EUVIMEDEUVIMED entdecken
Crossref

Lucidumones L-P: Meroterpenoids from Ganoderma lucidum and their inhibitory effect on triple negative breast cancer

Jiao-Jiao Zhang, Ze-Hong Wu, Yuan-Nan Yuan, Dan Cai, Jia-Wang Liu, Hong Zhou, Zhong-Hui Yang, Yan-Jiao Yin, Yong-Xian Cheng

Phytochemistry · 2026-09 · 249 · 114927

DOI: 10.1016/j.phytochem.2026.114927 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytochemistry, 2026-09. Verfasst von Jiao-Jiao Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Key Laboratory of Chinese Medicine Ingredients and Gut Microbiomics, School of Pharmacy, Shenzhen University Medical School, Shenzhen Unive…. Hauptthemen laut MEDLINE: Terpenes, Triple Negative Breast Neoplasms, Reishi, Antineoplastic Agents, Phytogenic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Shenzhen Municipal Fundamental Research Program, Chengdu University of Traditional Chinese Medicine, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Meroterpenoids in Ganoderma mushrooms have attracted attention in recent years. In this effort, lucidumones L-P (1-5), five undescribed meroterpenoids, including four without chirality (1-4) and a pair of enantiomers (5), were isolated from G. lucidum. Their structures were elucidated using spectroscopic and computational methods. Compound 1 was structurally characterized as a decarbonized dimeric meroterpenoid. Compounds 2 and 3 possess significant inhibitory effects on the cell migration of MDA-MB-231 cells, and compound 2 inhibits the cell migration dose-dependently.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TerpenesTriple Negative Breast NeoplasmsReishiAntineoplastic Agents, PhytogenicHumansMolecular StructureCell MovementDrug Screening Assays, AntitumorDose-Response Relationship, DrugMDA-MB-231 CellsStructure-Activity RelationshipCell ProliferationFemale

Stichwörter der Autor:innen

Ganoderma lucidumGanodermataceaeMeroterpenoidTriple negative breast cancer

Substanzen

TerpenesAntineoplastic Agents, Phytogenic

Autor:innen und Institutionen

  • Guangdong Key Laboratory of Chinese Medicine Ingredients and Gut Microbiomics, School of Pharmacy, Shenzhen University Medical School, Shenzhen University, Shenzhen, 518060, People's Republic of China.
  • State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100050, People's Republic of China.
  • Guangdong Key Laboratory of Chinese Medicine Ingredients and Gut Microbiomics, School of Pharmacy, Shenzhen University Medical School, Shenzhen University, Shenzhen, 518060, People's Republic of China; State Key Laborat…

Förderung

  • Shenzhen Municipal Fundamental Research Program
  • Chengdu University of Traditional Chinese Medicine
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, J. J., Wu, Z. H., Yuan, Y. N., Cai, D., Liu, J. W., Zhou, H., Yang, Z. H., Yin, Y. J., & Cheng, Y. X. (2026). Lucidumones L-P: Meroterpenoids from Ganoderma lucidum and their inhibitory effect on triple negative breast cancer. Phytochemistry, 249, 114927. https://doi.org/10.1016/j.phytochem.2026.114927

Vancouver

Zhang JJ, Wu ZH, Yuan YN, Cai D, Liu JW, Zhou H, et al. Lucidumones L-P: Meroterpenoids from Ganoderma lucidum and their inhibitory effect on triple negative breast cancer. Phytochemistry. 2026;249:114927. doi:10.1016/j.phytochem.2026.114927

BibTeX
@article{Zhang2026,
  author = {Zhang, Jiao-Jiao and Wu, Ze-Hong and Yuan, Yuan-Nan and Cai, Dan and Liu, Jia-Wang and Zhou, Hong and Yang, Zhong-Hui and Yin, Yan-Jiao and Cheng, Yong-Xian},
  title = {Lucidumones L-P: Meroterpenoids from Ganoderma lucidum and their inhibitory effect on triple negative breast cancer},
  journal = {Phytochemistry},
  year = {2026},
  volume = {249},
  pages = {114927},
  doi = {10.1016/j.phytochem.2026.114927}
}
Kostenlos starten →